ReviewLife sciences, society and policy2020

Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer's disease.

Misha Angrist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.